Drug
Secnidazole
Secnidazole: highest development phase Post-Market, developed by Lupin. 2 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Lupin
Trials
| Drug | Phase | Indication |
|---|---|---|
| Secnidazole NCT03937869 | Post-Market | Bacterial Vaginoses |
| Secnidazole NCT03935217 | Phase 3 | Trichomonas Infection |
Latest
No recent events.
Follow Secnidazole on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.